glp 3rt retatrutide GLP-3 Retatrutide (24mg vials) -

It is closer to the injectable semaglutide range than to tirzepatide

Traditionally GLP-1(9-36) was considered inactive, however more recent studies indicate that GLP-1(9-36) can contribute to inhibiting glucagon secretion by inhibiting voltage-gated calcium channels through a GPCR mechanism, an effect which reduces the number of glucagon containing vesicles that are available for exocytosis, thereby contributing the the decrease in glucagon secretion (Figure 1)(Zheng et al, 2024)

Especially tell your doctor if you take water pills (diuretics) or medicines that can lower your blood sugar such as insulin

GIPGLP1 receptor agonist shows promise